Skip to main content

Brevan Howard Capital Management LP

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1512857 ST. HELIER, Y9

Position in SNDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,756,160
+$1,970,981 QoQ
Shares Held
309,065
+50.9% QoQ
Ownership
0.346%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#61
of 238 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $183,834,510 across 129 Biotechnology names. SNDX ranks #7 (3.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 SNDX
Syndax Pharmaceuticals Inc
This page
309,065 $6,756,160

All Filings in SNDX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,756,160 309,065
2026-03-31 $4,785,179 204,845
2025-12-31 $10,822,859 515,129
2025-09-30 $1,916,586 124,575
2025-06-30 $264,345 28,227
2025-03-31 $741,239 60,337
2024-12-31 $186,018 14,071
2024-09-30 $436,685 22,685